Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1833944

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1833944

Male Infertility Global Market Opportunities And Strategies To 2034

PUBLISHED:
PAGES: 332 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Male infertility is a medical condition in which a man has a reduced ability or inability to cause pregnancy in a fertile female partner. It is commonly caused by issues such as low sperm count, poor sperm motility, abnormal sperm shape, hormonal imbalances, genetic defects, or blockages in the reproductive tract. The primary purpose of addressing male infertility is to identify and treat the underlying causes to improve the chances of natural conception or assist with reproduction through medical interventions.

The male infertility market consists of sales, by entities (organizations, sole traders and partnerships), of male infertility that are used by individuals or couples seeking to conceive, its treatment is sought whenever conception challenges arise, which can be at any age but most commonly in men 30-50 years old.

The global male infertility market was valued at $3,342.35 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 4.00%.

Rising Investments In R&D And Fertility Biotech

During the historic period, the rising investments in R&D and fertility biotech supported the growth of the male infertility market. These investments enabled the development of innovative diagnostic tools, advanced treatment options, and new technologies, helping companies improve success rates, address unmet medical needs, and expand their service offerings. As a result, businesses were able to enhance their competitive advantage, attract more patients, and strengthen their position in the growing fertility sector. For instance, in June 2025, according to the National Institutes of Health (NIH), a US-based government agency, reported that in 2024, the United States allocated $221 million to infertility research, reflecting an increase from the $216 million invested in 2023. Therefore, the rising investments in R&D and fertility biotech drove the growth of the male infertility market.

Advancing Male Infertility Diagnosis Through At-Home Fertility Test

Companies operating in the male infertility market are focusing on developing at-home fertility test for gaining competitive advantage. The at-home fertility test is designed to provide an easier and faster process to traditional fertility testing, a cheaper alternative to specialist appointments and to also alleviate pressure on the National Health Service (NHS). For instance, in June 2023, Newfoundland, a UK-based company specializing in the development and distribution of diagnostic health tests launched the fastest and most affordable at-home fertility test. The new test, which is available over the counter, gives fertility results in just five minutes and boasts 98.2 per cent accuracy. The new at-home Male Fertility test will give men the opportunity to understand more about their fertility and seek the right medical advice if needed.

The global male infertility markets is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 25.54% of the total market in 2024.

Male Infertility Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global male infertility market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for male infertility? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The male infertility market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider male infertility market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by source, by application and by end-user.
  • Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework:- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment source, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market
  • Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard: - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments: - Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for male infertility providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Treatment Type: Medication; Surgery; Assisted Reproductive Technology
  • 2) By Test Type: Sperm Agglutination; Deoxyribonucleic Acid Fragmentation Technique; Oxidative Stress Analysis; Computer Assisted Semen Analysis; Sperm Penetration Assay; Other Test Types
  • 3) By End-User: Hospitals And Clinics; Fertility Centers; Research Institutes; Other End-Users
  • Companies Mentioned: Bayer AG; Merck KGaA / Merck Serono; Zydus Lifesciences; Intas Pharmaceuticals Ltd; CooperSurgical Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; male infertility indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: o&s1739

Table of Contents

1 Executive Summary

  • 1.1 Male Infertility - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Male Infertility Market Definition And Segmentations
  • 6.4 Market Segmentation By Treatment Type
    • 6.4.1 Medication
    • 6.4.2 Surgery
    • 6.4.3 Assisted Reproductive Technology (ART)
  • 6.5 Market Segmentation By Test Type
    • 6.5.1 Sperm Agglutination
    • 6.5.2 Deoxyribonucleic Acid (DNA) Fragmentation Technique
    • 6.5.3 Oxidative Stress Analysis
    • 6.5.4 Computer Assisted Semen Analysis (CASA)
    • 6.5.5 Sperm Penetration Assay
    • 6.5.6 Other Test Types
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals and Clinics
    • 6.6.2 Fertility Centers
    • 6.6.3 Research Institutes
    • 6.6.4 Other End-Users

7 Major Market Trends

  • 7.1 Strategic Investments Driving Innovation In Reproductive Health Solutions
  • 7.2 Advancing Male Infertility Diagnosis Through At-Home Fertility Test
  • 7.3 Empowering Male Reproductive Health Through At-Home Diagnostic Innovation
  • 7.4 Strengthening Fertility Care Through Collaborative Digital Health Initiatives

8 Global Male Infertility Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Male Infertility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 End User Analysis (B2B)
    • 8.2.1 Hospitals And Clinics
    • 8.2.2 Fertility Centers
    • 8.2.3 Research Institutes
    • 8.2.4 Other End-Users
  • 8.3 Global Male Infertility Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Male Infertility Total Addressable Market (TAM)

9 Global Male Infertility Market Segmentation

  • 9.1 Global Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Male Infertility Market, Sub-Segmentation Of Medication, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Male Infertility Market, Sub-Segmentation Of Surgery, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Male Infertility Market, Sub-Segmentation Of Assisted Reproductive Technology (ART), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Male Infertility Market, Regional and Country Analysis

  • 10.1 Global Male Infertility Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Male Infertility Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 China Market
  • 11.7 Summary
  • 11.8 Market Overview
    • 11.8.1 Country Information
    • 11.8.2 Market Information
    • 11.8.3 Background Information
    • 11.8.4 Government Initiatives
    • 11.8.5 Regulations
    • 11.8.6 Regulatory Bodies
    • 11.8.7 Major Associations
    • 11.8.8 Taxes Levied
    • 11.8.9 Corporate Tax Structure
    • 11.8.10 Major Companies
  • 11.9 China Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.10 China Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 India Market
  • 11.13 India Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.14 India Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 Japan Market
  • 11.17 Summary
  • 11.18 Market Overview
    • 11.18.1 Country Information
    • 11.18.2 Market Information
    • 11.18.3 Background Information
    • 11.18.4 Government Initiatives
    • 11.18.5 Regulations
    • 11.18.6 Regulatory Bodies
    • 11.18.7 Major Associations
    • 11.18.8 Taxes Levied
    • 11.18.9 Corporate Tax Structure
    • 11.18.10 Investments
    • 11.18.11 Major Companies
  • 11.19 Japan Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.20 Japan Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Australia Market
  • 11.23 Australia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.24 Australia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Indonesia Market
  • 11.27 Indonesia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 Indonesia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 South Korea Market
  • 11.31 Summary
  • 11.32 Market Overview
    • 11.32.1 Country Information
    • 11.32.2 Market Information
    • 11.32.3 Background Information
    • 11.32.4 Government Initiatives
    • 11.32.5 Regulations
    • 11.32.6 Regulatory Bodies
    • 11.32.7 Major Associations
    • 11.32.8 Taxes Levied
    • 11.32.9 Corporate Tax Structure
    • 11.32.10 Investments
    • 11.32.11 Major Companies
  • 11.33 South Korea Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.34 South Korea Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Male Infertility Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Male Infertility Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Region Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Major Companies
  • 14.16 Canada Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Marke Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Male Infertility Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Bayer AG
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Financial Overview
  • 18.3 Merck KGaA / Merck Serono
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Zydus Lifesciences
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Intas Pharmaceuticals Ltd
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Financial Overview
  • 18.6 CooperSurgical Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Vitrolife Group (Vitrolife AB)
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 CinnaGen Co.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Kindbody Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Aytu BioScience Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Fortis Healthcare Ltd.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 FUJIFILM Irvine Scientific Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Boston IVF
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Aprilbio Co. Ltd.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Paterna Biosciences Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 SCSA Diagnostics Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Give Legacy Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 ReproNovo SA
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Andrology Solutions Ltd.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Inherent Biosciences Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Posterity Health Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 NewGenIvf Acquires Microsort Technology From GIVF To Expand Fertility Capabilities
  • 22.2 CooperSurgical Acquires ZyMot Fertility To Strengthen ART Capabilities
  • 22.3 Ro Acquires Dadi To Expand Digital Male Fertility Solutions

23 Recent Developments In Male Infertility

  • 23.1 Innovative AI Technology Revolutionizes Treatment For Severe Male Infertility
  • 23.2 Revolutionizing Male Fertility Testing With Portable, Accurate Home Diagnostics

24 Opportunities And Strategies

  • 24.1 Global Male Infertility Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Male Infertility Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Male Infertility Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Male Infertility Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!